Alibaba Financial Statements From 2010 to 2025
| ALBHF Stock | USD 0.74 0.04 5.71% |
Check Alibaba Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Alibaba Health's main balance sheet or income statement drivers, such as , as well as many indicators such as . Alibaba financial statements analysis is a perfect complement when working with Alibaba Health Valuation or Volatility modules.
Alibaba |
Alibaba Health Information Company Current Valuation Analysis
Alibaba Health's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Alibaba Health Current Valuation | 14.83 B |
Most of Alibaba Health's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Alibaba Health Information is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Alibaba Health Information has a Current Valuation of 14.83 B. This is 3.26% higher than that of the Healthcare sector and significantly higher than that of the Pharmaceutical Retailers industry. The current valuation for all United States stocks is 10.78% higher than that of the company.
Alibaba Health Infor Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Alibaba Health's current stock value. Our valuation model uses many indicators to compare Alibaba Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Alibaba Health competition to find correlations between indicators driving Alibaba Health's intrinsic value. More Info.Alibaba Health Information is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Alibaba Health's earnings, one of the primary drivers of an investment's value.About Alibaba Health Financial Statements
Alibaba Health stakeholders use historical fundamental indicators, such as Alibaba Health's revenue or net income, to determine how well the company is positioned to perform in the future. Although Alibaba Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in Alibaba Health's assets and liabilities are reflected in the revenues and expenses on Alibaba Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Alibaba Health Information. Please read more on our technical analysis and fundamental analysis pages.
Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. Alibaba Health Information Technology Limited is based in Causeway Bay, Hong Kong. Alibaba Health operates under Pharmaceutical Retailers classification in the United States and is traded on OTC Exchange. It employs 1849 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Alibaba Pink Sheet
Alibaba Health financial ratios help investors to determine whether Alibaba Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Alibaba with respect to the benefits of owning Alibaba Health security.